Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice
- Aubrey C Cantrell 1, Jessie Besanson 1, Quinesha Williams 1, Ngoc Hoang 1, Kristin Edwards 1, G Reid Bishop 1, Yingjie Chen 2, Heng Zeng 1, Jian-Xiong Chen 1
- 1Department of Pharmacology & Toxicology, University of Mississippi Medical Center, School of Medicine, Jackson, MS 39216, USA.
- 2Department of Physiology & Biophysics, University of Mississippi Medical Center, School of Medicine, Jackson, MS 39216, USA.
- 0Department of Pharmacology & Toxicology, University of Mississippi Medical Center, School of Medicine, Jackson, MS 39216, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mitochondrial ferroptosis, driven by Sirtuin 3 (SIRT3) loss in heart cells, causes heart failure. Inhibiting ferroptosis with ferrostatin-1 improved heart function by targeting mitochondrial pathways.
Area Of Science
- Cardiovascular Research
- Mitochondrial Biology
- Cell Death Mechanisms
Background
- Ferroptosis, an iron-dependent cell death, is implicated in ischemic heart disease.
- Sirtuin 3 (SIRT3) is linked to ferroptosis and cardiac fibrosis.
- Mitochondrial dysfunction is a key factor in heart failure.
Purpose Of The Study
- To investigate if SIRT3 knockout in cardiomyocytes (SIRT3cKO) promotes mitochondrial ferroptosis.
- To determine if blocking ferroptosis can ameliorate mitochondrial dysfunction in the context of SIRT3 deficiency.
- To explore the role of SIRT3 as a mitochondrial deacetylase in ferroptosis.
Main Methods
- Comparative analysis of mitochondrial and cytosolic fractions from SIRT3cKO and SIRT3loxp mice.
- Echocardiography to assess cardiac function (EF% and FS%).
- Analysis of protein acetylation, key ferroptosis regulators (GPX4, frataxin, aconitase), and oxidative stress markers (4-hydroxynonenal).
- Treatment with ferroptosis inhibitor ferrostatin-1 (Fer-1) in SIRT3cKO mice.
Main Results
- SIRT3cKO mice exhibited heart failure with reduced EF% and FS%.
- Loss of SIRT3 led to increased mitochondrial acetylation, including acetylated p53, and decreased mitochondrial GPX4, frataxin, and aconitase.
- Ferrostatin-1 treatment improved cardiac function, increased GPX4 and aconitase, and restored mitochondrial integrity in SIRT3cKO mice.
Conclusions
- SIRT3 is a critical mitochondrial deacetylase regulating ferroptosis.
- Inhibition of ferroptosis ameliorates cardiac dysfunction by targeting mitochondrial aconitase and iron-sulfur clusters.
- Blocking mitochondrial ferroptosis presents a potential therapeutic strategy for mitochondrial cardiomyopathies.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:46
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
01:30
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

